ArticleJournal of glaucoma2016
Why Patients With Glaucoma Lose Vision: The Patient Perspective.
Article in Journal of glaucoma, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03159247 (The eyeGuide), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program
Who cites it
14 citing papers in PubMed.
- Impact of polygeNic risk score for glaucoma on psycHosocial ouTcomes (INSiGHT) study protocol.PloS one · 2024Article
- Interventional Glaucoma: Improving the Patient-Provider Educational Exchange.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Factors Associated with Non-Adherence to Glaucoma Treatment in a Korean Nationwide Survey.Iranian journal of public health · 2022Article
- Article
- Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.Journal of glaucoma · 2020Article
- Psychosocial Predictors of Glaucoma Medication Adherence Among the Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Pilot Study Participants.American journal of ophthalmology · 2020Article
- Decreasing Avoidable Vision Loss: Identifying Antecedents of Adherence.Clinical ophthalmology (Auckland, N.Z.) · 2020Article
- Glaucoma Adherence-From Theriac to the Future.American journal of ophthalmology · 2018Article
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy.Clinical ophthalmology (Auckland, N.Z.) · 2018Review
- Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design.Pilot and feasibility studies · 2018Article
- The impact of matrix metalloproteinases and their tissue inhibitors in patients with chronic glaucoma - a literature review.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieReview
- Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy.Ophthalmology. GlaucomaArticle
- Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program.Ophthalmology. GlaucomaArticle
- A scoping review of patients' barriers to eye care for glaucoma and keratitis.Survey of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeTo explore why glaucoma patients believe that glaucoma continues to cause vision loss despite the availability of effective treatment.
methodsNine focus groups were conducted in 3 geographically and ethnically diverse areas of the United States (Los Angeles, CA; Rochester, MN; Durham, NC) that included 56 participants, 31 with poor vision and 25 with good vision. Content analysis was used to identify important themes. Semiquantitative analysis was used to measure the frequency of each theme.
resultsA total of 474 relevant comments were made in the 9 focus groups. Focus groups elicited 305 comments about barriers to glaucoma management including issues with adherence (30%), the doctor-patient relationship (21%), knowledge about glaucoma (19%), personal support systems (19%), and barriers to health care delivery such as cost and insurance (11%). A total of 101 comments were made regarding feelings about glaucoma and 58 comments were made regarding beliefs about disease and treatment.
conclusionsThese focus groups brought up many issues surrounding barriers to glaucoma treatment, perceived susceptibility to glaucoma, perceived benefits to treatment, and the emotional response to living with glaucoma. There is a need to create a more comprehensive chronic disease management approach for patients with glaucoma to address both the concrete and emotional issues identified in these focus group discussions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.